NCT01897571 2024-03-26Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCLIpsenPhase 1/2 Completed400 enrolled 22 charts 2 FDA
NCT01724021 2018-01-23A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3aHoffmann-La RochePhase 3 Completed743 enrolled 16 charts
NCT00379574 2013-03-15Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCLAsan Medical CenterPhase 1/2 Completed49 enrolled 8 charts